Adrenocortical Carcinoma: Single Center Experience
نویسندگان
چکیده
منابع مشابه
Basal Cell Carcinoma: A Single-Center Experience
Background. Basal cell carcinoma comprises the vast majority of skin cancers. It predominantly affects fair-skinned individuals, and its incidence is rising rapidly. Etiology may be multifactorial, but sun exposure appears to play a critical role. When detected early, the prognosis is excellent. Thus appropriate diagnosis, treatment, and surveillance are of utmost importance. Methods. From Janu...
متن کاملFetal Echocardiography Indications: A Single- Center Experience
Background Congenital heart disease (CHD) is the most common lethal congenital anomaly. Early diagnosis of CHD by fetal echocardiography based on maternal and fetal indications is important and lifesaving. The aim of study was to assess the referral aspects of pregnant women to pediatric cardiologist. Materials and Methods This was a retrospective cross-sectional study on 250 documents of refer...
متن کاملManagement of hepatocellular carcinoma -- experience of a single center.
BACKGROUND AND AIMS Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the third most common cause of cancer-related death. We aim to study the diagnosis and treatment options for HCC. METHODS We used standard methods of diagnosis for HCC:radiology, determining serum alpha fetoprotein (AFP). We included 190 patients diagnosed with HCC between April 2011 and May 2012....
متن کاملSarcomatoid Urothelial Carcinoma: A Single Cancer Center Experience
Background Sarcomatoid bladder cancer is a rare and aggressive variant of urothelial carcinoma. Methods A retrospective review of our experience in managing patients with sarcomatoid bladder cancer (SRBC) between 1997 and 2011 was performed to better define the behavior and outcomes of this disease. Results The median age of the patients was 63 years. All patients presented with high grade ...
متن کاملAxitinib in metastatic renal cell carcinoma: single center experience
AIM OF THE STUDY Due to the emergence of new therapeutic opportunities in the second-line treatment of metastatic renal cell carcinoma, the choice of the appropriate medication requires consideration. Making the selection one should take into account the likelihood of response, the probability of toxicity, properties of the drug and the clinical characteristics of the patient. Aim of the work w...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Archives of Medical Research
سال: 2020
ISSN: 2651-3137,2651-3153
DOI: 10.4274/eamr.galenos.2019.25744